RARA and acute promyelocytic leukemia: The classical mechanism believed to underlay the molecular pathology of APL is based on the contention that PML-RARα exerts a dominant negative effect on the transcription of RARα target genes, which impairs their responsiveness to physiological concentrations of ATRA6.